SCHEMBL810795

SCHEMBL810795

O=S(=O)(Nc1ccc(NS(=O)(=O)c2ccccc2)cc1)c1ccccc1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.91
MEN1 O00255 4/20 0.91
PKM P14618 2/20 0.91
ALDH1A1 P00352 1/20 0.91
KEAP1 Q14145 2/20 0.91
IL1RN P18510 1/20 0.91
ERAP1 Q9NZ08 1/20 0.91
CA12 O43570 2/20 0.77
CA1 P00915 2/20 0.77
CA2 P00918 2/20 0.77
CA9 Q16790 2/20 0.77
HPGD P15428 2/20 0.74
MAPT P10636 1/20 0.74
PGR P06401 1/20 0.74
LMNA P02545 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
NR1I2 O75469 1/20 0.67
HTR6 P50406 1/20 0.67
UQCRB P14927 2/20 0.63
GAA P10253 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9001182 0.95 KMT2A (1.00) KMT2AMEN1PKMALDH1A1KEAP1
Phenyl(Phenylsulfonyl)Amine SCHEMBL114765 0.95 KEAP1 (1.00) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL25031372 0.95 KEAP1 (1.00) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL13167612 0.93 KMT2A (0.80) KMT2AMEN1PKMALDH1A1KEAP1
Phenyl(Phenylsulfonyl)Amine SCHEMBL11513007 0.93 KEAP1 (0.95) KMT2AMEN1PKMALDH1A1KEAP1
Phenyl(Phenylsulfonyl)Amine SCHEMBL6399560 0.93 KEAP1 (0.95) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL3686387 0.91 KMT2A (0.84) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL523562 0.91 KMT2A (0.77) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL9001183 0.91 KMT2A (0.84) KMT2AMEN1PKMALDH1A1KEAP1
Lithium SCHEMBL31041155 0.91 KMT2A (0.77) KMT2AMEN1PKMALDH1A1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080146548-A1 AMIDE, ARYL SULFONAMIDE, ARYL UREA, AND a,b-DIKETONE DERIVED CARBOXYLESTERASE INHIBITORS, AND THEIR METHODS OF USE ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2008-06-19 US claimed
US-20050054691-A1 Carboxylesterase inhibitors ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2005-03-10 US claimed
WO-2005021721-A2 CARBOXYLESTERASE INHIBITORS ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2005-03-10 WO claimed
US-5264474-A Plasticizing thermoplastic or thermosetting resins with sulfonamide compounds MTM AMERICAS INC. (US) 1993-11-23 US claimed
US-4981890-A POLYHALOAROMATIC AND AROMATIC BIS-SULFONAMIDE ETHYL CORPORATION (US) 1991-01-01 US claimed
US-4957958-A IMPROVED MELT FLOW ETHYL CORPORATION (US) 1990-09-18 US claimed
US-20230288610-A1 WAVELENGTH SELECTIVE ABSORPTION FILTER AND DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-09-14 US disclosed
EP-2998359-B1 METHOD FOR IMPROVING THE ELECTRICAL-INSULATING PROPERTY AND THE FOGGING RESISTANCE OF A POLYESTER RESIN COMPOSITION ADEKA CORP (JP) 2019-08-21 EP disclosed
US-9726932-B2 Optical film, optical compensation film, polarizing plate and liquid crystal display FUJIFILM CORPORATION (JP) 2017-08-08 US disclosed
US-9726932-B2 Optical film, optical compensation film, polarizing plate and liquid crystal display FUJIFILM CORPORATION (JP) 2017-08-08 US disclosed
EP-2484725-B1 POLYESTER RESIN COMPOSITION, POLYESTER FIBER, POLYESTER RESIN MOLDED ARTICLE, AND PROCESS FOR PRODUCTION OF NUCLEATING AGENT FOR POLYESTER RESIN ADEKA CORP (JP) 2017-07-19 EP disclosed
EP-2407514-B1 REINFORCED POLYESTER RESIN COMPOSITION ADEKA CORP (JP) 2017-03-01 EP disclosed
US-9563075-B2 Method for manufacturing liquid crystal display device provided with front plate, and liquid crystal display device provided with front plate Konica Minolta, Inc. (JP) 2017-02-07 US disclosed
WO-1999041756-A1 INTRINSICALLY CONDUCTIVE POLYMER BLENDS HAVING A LOW PERCOLATION THRESHOLD ZIPPERLING KESSLER & CO. (GMBH & CO.) (DE) 1999-08-19 WO disclosed
WO-1999019391-A1 INTRINSICALLY CONDUCTIVE POLYMER/PLASTICIZER BLENDS WITH ENHANCED CONDUCTIVITY ZIPPERLING KESSLER & CO. (GMBH & CO.) (DE) 1999-04-22 WO disclosed
US-5871671-A Intrinsically conductive polymer/plasticizer blends with enhanced conductivity MONSANTO COMPANY (US) 1999-02-16 US disclosed
US-5468868-A Process for the selective chlorination of 4,5-dihydro-1-phenyl-1H-1,2,4-triazol-5-one FMC CORPORATION (US) 1995-11-21 US disclosed
US-5264474-A Plasticizing thermoplastic or thermosetting resins with sulfonamide compounds MTM AMERICAS INC. (US) 1993-11-23 US disclosed
US-4981890-A POLYHALOAROMATIC AND AROMATIC BIS-SULFONAMIDE ETHYL CORPORATION (US) 1991-01-01 US disclosed
US-4957958-A IMPROVED MELT FLOW ETHYL CORPORATION (US) 1990-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054691-A1 Carboxylesterase inhibitors CES1, CES2, BCHE KMT2A 1241/4885MEN1 4615/4885PKM 705/4885
US-20080146548-A1 AMIDE, ARYL SULFONAMIDE, ARYL UREA, AND a,b-DIKETONE DERIVED CARBOXYLESTERASE INHIBITORS, AND THEIR METHODS OF USE CES1, BCHE, CES2 KMT2A 943/4885MEN1 4755/4885PKM 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.